What are the side effects of Revuforj (Revumenib)?
Revuforj (Revumenib) is a new oral small molecule drug mainly used to treat relapsed or refractory acute leukemia in adults and children 1 year of age and older with lysine transferase 2A gene (KMT2A) translocation. Although this drug brings new treatment hope to patients, its use is also accompanied by certain adverse reactions and risks.
Among the common adverse reactions, bleeding and infection are the most prominent problems. Due to the bone marrow suppression that may be caused by acute leukemia itself and during treatment, patients often exhibit symptoms such as fever, neutropenia, and bacterial infection after taking Revuforj. These conditions not only affect the patient's quality of life, but may also have a negative impact on the effectiveness of treatment. In addition, nausea, musculoskeletal pain, and fatigue are also relatively common side effects, and these symptoms may affect patients' daily activities and mental state.

Diarrhea, constipation, and loss of appetite are also important concerns when it comes to the digestive system. Adverse reactions in the digestive system can lead to malabsorption of nutrients, affecting the patient's overall health and recovery. In terms of laboratory examinations, Revuforj may cause a series of abnormalities in biochemical indicators. Common laboratory abnormalities include elevated phosphate, aspartate aminotransferase, and alanine aminotransferase, as well as increased triglycerides and decreased potassium.
More serious side effects include differentiation syndrome, a potentially fatal complication associated with many treatments for leukemia. Symptoms of differentiation syndrome include fever, dyspnea, weight gain, and multiorgan dysfunction, and should prompt immediate intervention. In addition, QTc interval prolongation is also a problem that must be vigilant when using Revuforj. QTc prolongation may cause arrhythmia and even be life-threatening.
Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6eb3cdbc-0e74-477d-82d6-3bb172d3f63f
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)